Key factors in experimental mouse hematopoietic stem cell transplantation

Archivum Immunologiae et Therapiae Experimentalis

Volumn 54, Issue 4, 2006, Pages 253-269

  Nevozhay, Dmitry ^a   Opolski, Adam ^a  

^a INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

Author keywords

Chimerism; Engraftment; Hematopoietic stem cell transplantation; Mouse models

Indexed keywords

CHIMERA; EXPERIMENTAL MOUSE; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOPATHOGENESIS; IMMUNOREGULATION; NONHUMAN; REVIEW; TECHNIQUE;

ANIMALS; GRAFT REJECTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; MICE; MODELS, ANIMAL; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; TRANSPLANTATION CHIMERA; TRANSPLANTATION CONDITIONING; TRANSPLANTATION TOLERANCE;

EID: 33747177351     PISSN: 0004069X     EISSN: 16614917     Source Type: Journal    
DOI: 10.1007/s00005-006-0030-2     Document Type: Review

References (166)

1. Adams A. B., Durham M. M., Kean L., Shirasugi N., Ha J., Williams M. A., Rees P. A., Cheung M. C., Mittelstaedt S., Bingaman A. W., Archer D. R., Pearson T. C., Waller E. K. and Larsen C. P. (2001): Costimulation blockade, busulfan, and bone marrow promote titratable macrochimerism, induce transplantation tolerance, and correct genetic hemoglobinopathies with minimal myelosuppression. J. Immunol., 167, 1103-1111.
2. Asai O., Longo D. L., Tian Z. G., Hornung R. L., Taub D. D., Ruscetti F. W. and Murphy W. J. (1998): Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation. J. Clin. Invest, 101, 1835-1842.
3. Askenasy N. and Farkas D. L. (2002): Antigen barriers or available space do not restrict in situ adhesion of hemopoietic cells to bone marrow stroma. Stem Cells, 20, 80-85.
4. Bachar-Lustig E., Reich-Zeliger S. and Reisner Y. (2003): Anti-third-party veto CTLs overcome rejection of hematopoietic allografts: synergism with rapamycin and BM cell dose. Blood, 102, 1943-1950.
5. Balazs A. B., Fabian A. J., Esmon C. T. and Mulligan R. C. (2006): Endothelial protein C receptor (CD201) explicitly identifies hematopoietic stem cells in murine bone marrow. Blood, 107, 2317-2321.
6. Basch R. S., Quito F. L., Beh J. and Hirst J. A. (1997): Growth of human hematopoietic cells in immunodeficient mice conditioned with cyclophosphamide and busulfan. Stem Cells, 15, 314-323.
7. Bhattacharya D., Rossi D. J., Bryder D. and Weissman I. L. (2006): Purified hematopoietic stem cell engraftment of rare niches corrects severe lymphoid deficiencies without host conditioning. J. Exp. Med., 203, 73-85.
8. Blaha P., Bigenzahn S., Koporc Z., Schmid M., Langer F., Selzer E., Bergmeister H., Wrba F., Kurtz J., Kiss C., Roth E., Muehlbacher F., Sykes M. and Wekerle T. (2003): The influence of immunosuppressive drugs on tolerance induction through bone marrow transplantation with costimulation blockade. Blood, 101, 2886-2893.
9. Calvi L. M., Adams G. B., Weibrecht K. W., Weber J. M., Olson D. P., Knight M. C., Martin R. P., Schipani E., Divieti P., Bringhurst F. R., Milner L. A., Kronenberg H. M. and Scadden D. T. (2003): Osteoblastic cells regulate the haematopoietic stem cell niche. Nature, 425, 841-846.
10. Cao Y. A., Wagers A. J., Beilhack A., Dusich J., Bachmann M. H., Negrin R. S., Weissman I. L. and Contag C. H. (2004): Shifting foci of hematopoiesis during reconstitution from single stem cells. Proc. Natl. Acad. Sci. USA, 101, 221-226.
11. Cetkovic-Cvrlje M., Roers B. A., Waurzyniak B., Liu X. P. and Uckun F. M. (2001): Targeting Janus kinase 3 to attenuate the severity of acute graft-versus-host disease across the major histocompatibility barrier in mice. Blood, 98, 1607-1613.
12. Chen B. J., Cui X., Sempowski G. D., Domen J. and Chao N. J. (2004): Hematopoietic stem cell dose correlates with the speed of immune reconstitution after stem cell transplantation. Blood, 103, 4344-4352.
13. Chen B. J., Cui X., Sempowski G. D., Gooding M. E., Liu C., Haynes B. F. and Chao N. J. (2002): A comparison of murine T-cell-depleted adult bone marrow and full-term fetal blood cells in hematopoietic engraftment and immune reconstitution. Blood, 99, 364-371.
14. Chen B. J., Morris R. E. and Chao N. J. (2000): Graft-versus-host disease prevention by rapamycin: cellular mechanisms. Biol. Blood Marrow Transplant., 6, 529-536.
15. Chen C. Z., Li M., de Graaf D., Monti S., Gottgens B., Sanchez M. J., Lander E. S., Golub T. R., Green A. R. and Lodish H. F. (2002): Identification of endoglin as a functional marker that defines long-term repopulating hematopoietic stem cells. Proc. Natl. Acad. Sci. USA, 99, 15468-15473.
16. Cheshier S. H., Morrison S. J., Liao X. and Weissman I. L. (1999): In vivo proliferation and cell cycle kinetics of long-term self-renewing hematopoietic stem cells. Proc. Natl. Acad. Sci. USA, 96, 3120-3125.
17. Christensen J. L. and Weissman I. L. (2001): Flk-2 is a marker in hematopoietic stem cell differentiation: a simple method to isolate long-term stem cells. Proc. Natl. Acad. Sci. USA, 98, 14541-14546.
18. Colson Y. L., Wren S. M., Schuchert M. J., Patrene K. D., Johnson P. C., Boggs S. S. and Ildstad S. T. (1995): A non-lethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers. J. Immunol., 155, 4179-4188.
19. Colvin G. A., Lambert J. F., Abedi M., Hsieh C. C., Carlson J. E., Stewart F. M. and Quesenberry P. J. (2004): Murine marrow cellularity and the concept of stem cell competition: geographic and quantitative determinants in stem cell biology. Leukemia, 18, 575-583.
20. Contassot E., Robinet E., Angonin R., Laithier V., Bittencourt M., Pavy J. J., Cahn J. Y., Herve P. and Tiberghien P. (1998): Differential effects of cyclosporin A on the alloreactivity of fresh and ex vivo-expanded T lymphocytes. Bone Marrow Transplant, 22, 1097-1102.
21. Cooke K. R., Gerbitz A., Crawford J. M., Teshima T., Hill G. R., Tesolin A., Rossignol D. P. and Ferrara J. L. (2001): LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation. J. Clin. Invest, 107, 1581-1589.
22. Cui Y. Z., Hisha H., Yang G. X., Fan T. X., Tin T., Li Q., Lian Z. and Ikehara S. (2002): Optimal protocol for total body irradiation for allogeneic bone marrow transplantation in mice. Bone Marrow Transplant., 30, 843-849.
23. Davies J. K. and Lowdell M. W. (2003): New advances in acute graft-versus-host disease prophylaxis. Transfus. Med., 13, 387-397.
24. Deeg H. J. (2003): New strategies for prevention and treatment of graft-versus-host disease and for induction of graft-versus-leukemia effects. Int. J. Hematol., 77, 15-21.
25. de Haan G., Szilvassy S. J., Meyerrose T. E., Dontje B., Grimes B. and Van Zant G. (2000): Distinct functional properties of highly purified hematopoietic stem cells from mouse strains differing in stem cell numbers. Blood, 96, 1374-1379.
26. de La Selle V., Gluckman E. and Bruley-Rosset M. (1996): Newborn blood can engraft adult mice without inducing graft-versus-host disease across non H-2 antigens. Blood, 87, 3977-3983.
27. de La Selle V., Gluckman E. and Bruley-Rosset M. (1998): Graft-versus-host disease and graft-versus-leukemia effect in mice grafted with peripheral newborn blood. Blood, 92, 3968-3975.
28. Deng W., Han Q., Liao L., Li C., Ge W., Zhao Z., You S., Deng H. and Zhao R. C. (2004): Allogeneic bone marrow-derived flk-1+Sca-1- mesenchymal stem cells leads to stable mixed chimerism and donor-specific tolerance. Exp. Hematol., 32, 861-867.
29. de Vries-van der Zwan, van der Pol M. A., de Waal L. P. and Boog C. J. (1998): An alternative conditioning regimen for induction of specific skin graft tolerance across full major histocompatibility complex barriers. Transpl. Immunol., 6, 147-151.
30. Down J. D., Berman A. J., Warhol M., Van Dijken P. J., Ferrara J. L., Yeap B., Hellman S. and Mauch P. M. (1989): Late tissue-specific toxicity of total body irradiation and busulfan in a murine bone marrow transplant model. Int. J. Radiat. Oncol. Biol. Phys., 17, 109-116.
31. Down J. D., Boudewijn A., Dillingh J. H., Fox B. W. and Ploemacher R. E. (1994): Relationships between ablation of distinct haematopoietic cell subsets and the development of donor bone marrow engraftment following recipient pretreatment with different alkylating drugs. Br. J. Cancer, 70, 611-616.
32. Down J. D., Mauch P., Warhol M., Neben S. and Ferrara J. L. (1992): The effect of donor T lymphocytes and total-body irradiation on hemopoietic engraftment and pulmonary toxicity following experimental allogeneic bone marrow transplantation. Transplantation, 54, 802-808.
33. Down J. D. and Ploemacher R. E. (1993): Transient and permanent engraftment potential of murine hematopoietic stem cell subsets: differential effects of host conditioning with gamma radiation and cytotoxic drugs. Exp. Hematol., 21, 913-921.
34. Down J. D., Tarbell N. J., Thames H. D. and Mauch P. M. (1991): Syngeneic and allogeneic bone marrow engraftment after total body irradiation: dependence on dose, dose rate, and fractionation. Blood, 77, 661-669.
35. Duffner U. A., Maeda Y., Cooke K. R., Reddy P., Ordemann R., Liu C., Ferrara J. L. and Teshima T. (2004): Host dendritic cells alone are sufficient to initiate acute graft-versus-host disease. J. Immunol., 172, 7393-7398.
36. Edinger M., Hoffmann P., Ermann J., Drago K., Fathman C. G., Strober S. and Negrin R. S. 2003): CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nat. Med., 9, 1144-1150.
37. Ferrara J. L., Cooke K. R., Pan L. and Krenger W. (1996): The immunopathophysiology of acute graft-versus-host-disease. Stem Cells, 14, 473-489.
38. Ferrara J. L., Cooke K. R. and Teshima T. (2003): The pathophysiology of acute graft-versus-host disease. Int. J. Hematol., 78, 181-187.
39. Fleming W. H., Alpern E. J., Uchida N., Ikuta K., Spangrude G. J. and Weissman I. L. (1993): Functional heterogeneity is associated with the cell cycle status of murine hematopoietic stem cells. J. Cell Biol., 122, 897-902.
40. Fugier-Vivier I. J., Rezzoug F., Huang Y., Graul-Layman A. J., Schanie C. L., Xu H., Chilton P. M. and Ildstad S. T. (2005): Plasmacytoid precursor dendritic cells facilitate allogeneic hematopoietic stem cell engraftment. J. Exp. Med., 201, 373-383.
41. Gandy K. L., Domen J., Aguila H. and Weissman I. L. (1999): CD8+TCR+ and CD8+TCR- cells in whole bone marrow facilitate the engraftment of hematopoietic stem cells across allogeneic barriers. Immunity, 11, 579-590.
42. Gerbitz A., Schultz M., Wilke A., Linde H. J., Scholmerich J., Andreesen R. and Holler E. (2004): Probiotic effects on experimental graft-versus-host disease: let them eat yogurt. Blood, 103, 4365-4367.
43. Glass B., Uharek L., Gaska T., Gassmann W., Loffler H. and Muller-Ruchholtz W. (1993): The influence of graft-versus-host reactivity, lymphocyte depletion, and cell dose on allogeneic bone marrow engraftment. Bone Marrow Transplant., 12 (suppl. 3), S41-S47.
44. Glass B., Uharek L., Gassmann W., Focks B., Bolouri H., Loeffler H. and Mueller-Ruchholtz W. (1992): Graft-versus-leukemia activity after bone marrow transplantation does not require graft-versus-host disease. Ann. Hematol., 64, 255-259.
45. Glass B., Uharek L., Zeis M., Dreger P., Loffler H., Steinmann J. and Schmitz N. (1997): Allogeneic peripheral blood progenitor cell transplantation in a murine model: evidence for an improved graft-versus-leukemia effect. Blood, 90, 1694-1700.
46. Gong J. K. (1978): Endosteal marrow: a rich source of hematopoietic stem cells. Science, 199, 1443-1445.
47. Goodell M. A., Brose K., Paradis G., Conner A. S. and Mulligan R. C. (1996): Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J. Exp. Med., 183, 1797-1806.
48. Habibian H. K., Peters S. O., Hsieh C. C., Wuu J., Vergilis K., Grimaldi C. I., Reilly J., Carlson J. E., Frimberger A. E., Stewart F. M. and Quesenberry P. J. (1998): The fluctuating phenotype of the lymphohematopoietic stem cell with cell cycle transit. J. Exp. Med., 188, 393-398.
49. Harrison D. E. (1980): Competitive repopulation: a new assay for long-term stem cell functional capacity. Blood, 55, 77-81.
50. Harrison D. E. and Astle C. M. (1997): Short- and long-term multilineage repopulating hematopoietic stem cells in late fetal and newborn mice: models for human umbilical cord blood. Blood, 90, 174-181.
51. Hendrikx P. J., Martens C. M., Hagenbeek A., Keij J. F. and Visser J. W. (1996): Homing of fluorescently labeled murine hematopoietic stem cells. Exp. Hematol., 24, 129-140.
52. Hill G. R., Crawford J. M., Cooke K. R., Brinson Y. S., Pan L. and Ferrara J. L. (1997): Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines. Blood, 90, 3204-3213.
53. Hill G. R. and Ferrara J. L. (2000): The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation. Blood, 95, 2754-2759.
54. Huang S. L., Huang W. G., Xu H. G., Fang J. P., Wei J., Chen F. Y., Guo F. F. and Li S. N. (2002): Establishment of a murine model for allogeneic umbilical cord blood transplantation. Zhongguo Shi Yan. Xue. Ye. Xue. Za Zhi., 10, 564-567.
55. Imamura M. and Tanaka J. (2003): Immunoregulatory cells for transplantation tolerance and graft-versus-leukemia effect. Int. J. Hematol., 78, 188-194.
56. Ito T., Tajima F. and Ogawa M. (2000): Developmental changes of CD34 expression by murine hematopoietic stem cells. Exp. Hematol., 28, 1269-1273.
57. Johnson G. R., Dresch C. and Metcalf D. (1977): Heterogeneity in human neutrophil, macrophage and eosinophil progenitor cells demonstrated by velocity sedimentation separation. Blood, 50, 823-831.
58. Jordan C. T., Astle C. M., Zawadzki J., Mackarehtschian K., Lemischka I. R. and Harrison D. E. (1995): Long-term repopulating abilities of enriched fetal liver stem cells measured by competitive repopulation. Exp. Hematol., 23, 1011-1015.
59. Kim M., Cooper D. D., Hayes S. F. and Spangrude G. J. (1998): Rhodamine-123 staining in hematopoietic stem cells of young mice indicates mitochondrial activation rather than dye efflux. Blood, 91, 4106-4117.
60. Kim M., Moon H. B. and Spangrude G. J. (2003): Major age-related changes of mouse hematopoietic stem/progenitor cells. Ann. NY Acad. Sci., 996, 195-208.
61. Lan F., Zeng D., Higuchi M., Higgins J. P. and Strober S. (2003): Host conditioning with total lymphoid irradiation and antithymocyte globulin prevents graft-versus-host disease: the role of CD1-reactive natural killer T cells. Biol. Blood Marrow Transplant., 9, 355-363.
62. Lan F., Zeng D., Higuchi M., Huie P., Higgins J. P. and Strober S. (2001): Predominance of NK1.1+TCR alpha beta+ or DX5+TCR alpha beta+ T cells in mice conditioned with fractionated lymphoid irradiation protects against graft-versus-host disease: "natural suppressor" cells. J. Immunol., 167, 2087-2096.
63. Lapidot T., Lubin I., Terenzi A., Faktorowich Y., Erlich P. and Reisner Y. (1990): Enhancement of bone marrow allografts from nude mice into mismatched recipients by T cells void of graft-versus-host activity. Proc. Natl. Acad. Sci. USA, 87, 4595-4599.
64. Lapidot T., Terenzi A., Singer T. S., Salomon O. and Reisner Y. (1989): Enhancement by dimethyl myleran of donor type chimerism in murine recipients of bone marrow allografts. Blood, 73, 2025-2032.
65. Li C. L. and Johnson G. R. (1995): Murine hematopoietic stem and progenitor cells: I. Enrichment and biologic characterization. Blood, 85, 1472-1479.
66. Liang Y., Van Zant G. and Szilvassy S. J. (2005): Effects of aging on the homing and engraftment of murine hematopoietic stem and progenitor cells. Blood, 106, 1479-1487.
67. Lowsky R., Takahashi T., Liu Y. P., Dejbakhsh-Jones S., Grumet F. C., Shizuru J.A., Laport G. G., Stockerl-Goldstein K. E., Johnston L. J., Hoppe R. T., Bloch D. A., Blume K. G., Negrin R. S. and Strober S. (2005): Protective conditioning for acute graft-versus-host disease. N. Engl. J. Med., 353, 1321-1331.
68. Lu Y., Sakamaki S., Kuroda H., Kusakabe T., Konuma Y., Akiyama T., Fujimi A., Takemoto N., Nishiie K., Matsunaga T., Hirayama Y., Kato J., Kon S., Kogawa K. and Niitsu Y. (2001): Prevention of lethal acute graft-versus-host disease in mice by oral administration of T helper 1 inhibitor, TAK-603. Blood, 97, 1123-1130.
69. Luznik L., Jalla S., Engstrom L. W., Iannone R. and Fuchs E. J. (2001): Durable engraftment of major histocompatibility complex-incompatible cells after nonmyeloablative conditioning with fludarabine, low-dose total body irradiation, and posttransplantation cyclophosphamide. Blood, 98, 3456-3464.
70. Massa G., Wyllie J. P., Pratt A. M., Molineux G. and Schofield R. (1987): Marrow repopulation in mice treated with busulphan or isopropyl methane sulphonate and bone marrow. Br. J. Haematol., 66, 11-14.
71. Matsuzaki Y., Kinjo K., Mulligan R. C. and Okano H. (2004): Unexpectedly efficient homing capacity of purified murine hematopoietic stem cells. Immunity, 20, 87-93.
72. Mauch P., Down J. D., Warhol M. and Hellman S. (1988): Recipient preparation for bone marrow transplantation. I. Efficacy of total-body irradiation and busulfan. Transplantation, 46, 205-210.
73. Mencacci A., Perruccio K., Bacci A., Cenci E., Benedetti R., Martelli M. F., Bistoni F., Coffman R., Velardi A. and Romani L. (2001): Defective antifungal T-helper 1 (TH1) immunity in a murine model of allogeneic T-cell-depleted bone marrow transplantation and its restoration by treatment with TH2 cytokine antagonists. Blood, 97, 1483-1490.
74. Meng A., Wang Y., Brown S.A., Van Zant G. and Zhou D. (2003): Ionizing radiation and busulfan inhibit murine bone marrow cell hematopoietic function via apoptosis-dependent and -independent mechanisms. Exp. Hematol., 31, 1348-1356.
75. Merad M., Hoffmann P., Ranheim E., Slaymaker S., Manz M. G., Lira S. A., Charo I., Cook D. N., Weissman I. L., Strober S. and Engleman E. G. (2004): Depletion of host Langerhans cells before transplantation of donor alloreactive T cells prevents skin graft-versus-host disease. Nat. Med., 10, 510-517.
76. Migishima F., Oikawa A., Kondo S., Ema H., Morita Y., Nakauchi H., Yokoyama M., Song S. Y., Nishijima M., Okabe M. and Shinohara N. (2003): Full reconstitution of hematopoietic system by murine umbilical cord blood. Transplantation, 75, 1820-1826.
77. Monaco A. P. (2003): Chimerism in organ transplantation: conflicting experiments and clinical observations. Transplantation, 75 (suppl. 9), 13S-16S.
78. Morecki S., Leshem B., Eid A. and Slavin S. (1987): Alloantigen persistence in induction and maintenance of transplantation tolerance. J. Exp. Med., 165, 1468-1480.
79. Morecki S., Leshem B., Weigensberg M., Bar S. and Slavin S. (1985): Functional clonal deletion versus active suppression in transplantation tolerance induced by total-lymphoid irradiation. Transplantation, 40, 201-210.
80. Morris E. S., MacDonald K. P., Rowe V., Johnson D. H., Banovic T., Clouston A. D. and Hill G. R. (2004): Donor treatment with pegylated G-CSF augments the generation of IL-10-producing regulatory T cells and promotes transplantation tolerance. Blood, 103, 3573-3581.
81. Morrison S. J., Hemmati H. D., Wandycz A. M. and Weissman I. L. (1995): The purification and characterization of fetal liver hematopoietic stem cells. Proc. Natl. Acad. Sci. USA, 92, 10302-10306.
82. Morrison S. J., Qian D., Jerabek L., Thiel B. A., Park I. K., Ford P. S., Kiel M. J., Schork N. J., Weissman I. L. and Clarke M. F. (2002): A genetic determinant that specifically regulates the frequency of hematopoietic stem cells. J. Immunol., 168, 635-642.
83. Morrison S. J. and Weissman I. L. (1994): The long-term repopulating subset of hematopoietic stem cells is deterministic and isolatable by phenotype. Immunity, 1, 661-673.
84. Morrison S. J., Wright D. E. and Weissman I. L. (1997): Cyclophosphamide/granulocyte colony-stimulating factor induces hematopoietic stem cells to proliferate prior to mobilization. Proc. Natl. Acad. Sci. USA, 94, 1908-1913.
85. Neben S., Marcus K. and Mauch P. (1993): Mobilization of hematopoietic stem and progenitor cell subpopulations from the marrow to the blood of mice following cyclophosphamide and/or granulocyte colony-stimulating factor. Blood, 81, 1960-1967.
86. Olsen A. L., Stachura D. L. and Weiss M. J. (2006): Designer blood: creating hematopoietic lineages from embryonic stem cells. Blood, 107, 1265-1275.
87. Ordemann R., Hutchinson R., Friedman J., Burakoff S. J., Reddy P., Duffner U., Braun T. M., Liu C., Teshima T. and Ferrara J. L. (2002): Enhanced allostimulatory activity of host antigen-presenting cells in old mice intensifies acute graft-versus-host disease. J. Clin. Invest, 109, 1249-1256.
88. Pan L., Delmonte J. Jr., Jalonen C. K. and Ferrara J. L. (1995): Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-versus-host disease. Blood, 86, 4422-4429.
89. Pearce D. J., Ridler C. M., Simpson C. and Bonnet D. (2004): Multiparameter analysis of murine bone marrow side population cells. Blood, 103, 2541-2546.
90. Plautz G. E., Cohen P. A. and Shu S. (2003): Considerations on clinical use of T cell immunotherapy for cancer. Arch. Immunol. Ther. Exp., 51, 245-257.
91. Plett P. A., Frankovitz S. M. and Orschell C. M. (2003): Distribution of marrow repopulating cells between bone marrow and spleen early after transplantation. Blood, 102, 2285-2291.
92. Ploemacher R. E., van der Sluijs J. P., Voerman J. S. and Brons N. H. (1989): An in vitro limiting-dilution assay of long-term repopulating hematopoietic stem cells in the mouse. Blood, 74, 2755-2763.
93. Prigozhina T. B., Gurevitch O., Zhu J. and Slavin S. (1997): Permanent and specific transplantation tolerance induced by a nonmyeloablative treatment to a wide variety of allogeneic tissues: I. Induction of tolerance by a short course of total lymphoid irradiation and selective elimination of the donor-specific host lymphocytes. Transplantation, 63, 1394-1399.
94. Quesenberry P. J., Colvin G. and Abedi M. (2005): Perspective: fundamental and clinical concepts on stem cell homing and engraftment: a journey to niches and beyond. Exp. Hematol., 33, 9-19.
95. Quesenberry P. J., Colvin G. A., Abedi M., Lambert J. F., Moore B., Demers D., Greer D., McAuliffe C., Dooner M., Lum L. G., Badiavas E. and Falanga V. (2003): The marrow stem cell: the continuum. Bone Marrow Transplant., 32 (suppl. 1), S19-S22.
96. Quesenberry P. J., Stewart F. M., Becker P., D'Hondt L., Frimberger A., Lambert J. F., Colvin G. A., Miller C., Heyes C., Abedi M., Dooner M., Carlson J., Reilly J., McAuliffe C., Stencel K., Ballen K., Emmons R., Doyle P., Zhong S., Wang H. and Habibian H. (2001): Stem cell engraftment strategies. Ann. NY Acad. Sci., 938, 54-61.
97. Quesenberry P. J., Zhong S., Wang H. and Stewart M. (2001): Allogeneic chimerism with low-dose irradiation, antigen presensitization, and costimulator blockade in H-2 mismatched mice. Blood, 97, 557-564.
98. Ramshaw H. S., Rao S. S., Crittenden R. B., Peters S. O., Weier H. U. and Quesenberry P. J. (1995): Engraftment of bone marrow cells into normal unprepared hosts: effects of 5-fluorouracil and cell cycle status. Blood, 86, 924-929.
99. Randall T. D., Lund F. E., Howard M. C. and Weissman I. L. (1996): Expression of murine CD38 defines a population of long-term reconstituting hematopoietic stem cells. Blood, 87, 4057-4067.
100. Randall T. D. and Weissman I. L. (1997): Phenotypic and functional changes induced at the clonal level in hematopoietic stem cells after 5-fluorouracil treatment. Blood, 89, 3596-3606.
101. Rao S. S., Peters S. O., Crittenden R. B., Stewart F. M., Ramshaw H. S. and Quesenberry P. J. (1997): Stem cell transplantation in the normal nonmyeloablated host: relationship between cell dose, schedule, and engraftment. Exp. Hematol., 25, 114-121.
102. Ratajczak M. Z. (1990): Values of certain biochemical parameters in mouse serum after syngeneic bone marrow transplantation. Effect of various methods of myeloablation-immunosuppression preparation and recipient's age. Arch. Immunol. Ther. Exp., 38, 299-308.
103. Rebel V. I., Miller C. L., Eaves C. J. and Lansdorp P. M. (1996): The repopulation potential of fetal liver hematopoietic stem cells in mice exceeds that of their liver adult bone marrow counterparts. Blood, 87, 3500-3507.
104. Rebel V. I., Miller C. L., Spinelli J. J., Thomas T. E., Eaves C. J. and Lansdorp P. M. (1995): Nonlinear effects of radiation dose on donor-cell reconstitution by limited numbers of purified stem cells. Biol. Blood Marrow Transplant., 1, 32-39.
105. Rebel V. I., Miller C. L., Thornbury G. R., Dragowska W. H., Eaves C. J. and Lansdorp P. M. (1996): A comparison of long-term repopulating hematopoietic stem cells in fetal liver and adult bone marrow from the mouse. Exp. Hematol., 24, 638-648.
106. Reddy P., Maeda Y., Liu C., Krijanovski O. I., Korngold R. and Ferrara J. L. (2005): A crucial role for antigen-presenting cells and alloantigen expression in graft-versus-leukemia responses. Nat. Med., 11, 1244-1249.
107. Robbin W. G., Ploemacher R. E. and Down J. D. (1998): Maintaining high levels of syngeneic bone marrow engraftment while omitting cyclophosphamide in busulfan-containing conditioning regimens. Blood, 92, 1462-1463.
108. Roberts A. W. and Metcalf D. (1995): Noncycling state of peripheral blood progenitor cells mobilized by granulocyte colony-stimulating factor and other cytokines. Blood, 86, 1600-1605.
109. Ruggeri L., Capanni M., Urbani E., Perruccio K., Shlomchik W. D., Tosti A., Posati S., Rogaia D., Frassoni F., Aversa F., Martelli M. F. and Velardi A. (2002): Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science, 295, 2097-2100.
110. Salomon O., Lapidot T., Terenzi A., Lubin I., Rabi I. and Reisner Y. (1990): Induction of donor-type chimerism in murine recipients of bone marrow allografts by different radiation regimens currently used in treatment of leukemia patients. Blood, 76, 1872-1878.
111. Samlowski W. E., Araneo B. A., Butler M. O., Fung M. C. and Johnson H. M. (1989): Peripheral lymph node helper T-cell recovery after syngeneic bone marrow transplantation in mice prepared with either gamma-irradiation or busulfan. Blood, 74, 1436-1445.
112. Sanchez M. J., Holmes A., Miles C. and Dzierzak E. (1996): Characterization of the first definitive hematopoietic stem cells in the AGM and liver of the mouse embryo. Immunity, 5, 513-525.
113. Sato K., Yamashita N., Yamashita N., Baba M. and Matsuyama T. (2003): Regulatory dendritic cells protect mice from murine acute graft-versus-host disease and leukemia relapse. Immunity, 18, 367-379.
114. Scaradavou A., Isola L., Rubinstein P., Galperin Y., Najfeld V., Berlin D., Gordon J. and Weinberg R. S. (1997): A murine model for human cord blood transplantation: near-term fetal and neonatal peripheral blood cells can achieve long-term bone marrow engraftment in sublethally irradiated adult recipients. Blood, 89, 1089-1099.
115. Schofield R. (1978): The relationship between the spleen colony-forming cell and the haemopoietic stem cell. Blood Cells, 4, 7-25.
116. Sharabi Y. and Sachs D. H. (1989): Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen. J. Exp. Med., 169, 493-502.
117. Shirasugi N., Emmanouilidis N., Pearson T. C. and Larsen C. P. (2004): Ability of donor splenocytes with costimulation blockade to induce mixed hematopoietic chimerism and transplantation tolerance. Transplant. Proc., 36, 2423-2424.
118. Shizuru J. A., Jerabek L., Edwards C. T. and Weissman I. L. (1996): Transplantation of purified hematopoietic stem cells: requirements for overcoming the barriers of allogeneic engraftment. Biol. Blood Marrow Transplant., 2, 3-14.
119. Shlomchik W. D., Couzens M. S., Tang C. B., McNiff J., Robert M. E., Liu J., Shlomchik M. J. and Emerson S. G. (1999): Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science, 285, 412-415.
120. Slavin S., Fuks Z., Kaplan H. S. and Strober S. (1978): Transplantation of allogeneic bone marrow without graft-versus-host disease using total lymphoid irradiation. J. Exp. Med., 147, 963-972.
121. Slavin S., Morecki S., Weigensberg M., Bar S. and Weiss L. (1986): Functional clonal deletion versus suppressor cell-induced transplantation tolerance in chimeras prepared with a short course of total-lymphoid irradiation. Transplantation, 41, 680-687.
122. Slavin S., Morecki S., Weiss L. and Or R. (2003): Immunotherapy of hematologic malignancies and metastatic solid tumors in experimental animals and man. Crit Rev. Oncol. Hematol., 46, 139-163.
123. Slavin S. and Seidel H. J. (1982): Hemopoietic activity in bone marrow chimeras prepared with total lymphoid irradiation (TLI). Exp. Hematol., 10, 206-216.
124. Slavin S. and Strober S. (1979): Induction of allograft tolerance after total lymphoid irradiation (TLI): development of suppressor cells of the mixed leukocyte reaction (MLR). J. Immunol., 123, 942-946.
125. Slavin S., Strober S., Fuks Z. and Kaplan H. S. (1977): Induction of specific tissue transplantation tolerance using fractionated total lymphoid irradiation in adult mice: long-term survival of allogeneic bone marrow and skin grafts. J. Exp. Med., 146, 34-48.
126. Soderling C. C., Song C. W., Blazar B. R. and Vallera D. A. (1985): A correlation between conditioning and engraftment in recipients of MHC-mismatched T cell-depleted murine bone marrow transplants. J. Immunol., 135, 941-946.
127. Spangrude G. J., Heimfeld S. and Weissman I. L. (1988): Purification and characterization of mouse hematopoietic stem cells. Science, 241, 58-62.
128. Stewart F. M., Crittenden R. B., Lowry P. A., Pearson-White S. and Quesenberry P. J. (1993): Long-term engraftment of normal and post-5-fluorouracil murine marrow into normal nonmyeloablated mice. Blood, 81, 2566-2571.
129. Stewart F. M., Zhong S., Wuu J., Hsieh C., Nilsson S. K. and Quesenberry P. J. (1998): Lymphohematopoietic engraftment in minimally myeloablated hosts. Blood, 91, 3681-3687.
130. Suda T., Arai F. and Shimmura S. (2005): Regulation of stem cells in the niche. Cornea, 24 (suppl.), S12-S17.
131. Surdez D., Kunz B., Wagers A. J., Weissman I. L. and Terskikh A. V. (2005): Simple and efficient isolation of hematopoietic stem cells from H2K-zFP transgenic mice. Stem Cells, 23, 1617-1625.
132. Sutherland H. J., Lansdorp P. M., Henkelman D. H., Eaves A. C. and Eaves C. J. (1990): Functional characterization of individual human hematopoietic stem cells cultured at limiting dilution on supportive marrow stromal layers. Proc. Natl. Acad. Sci. USA, 87, 3584-3588.
133. Szilvassy S. J., Meyerrose T. E., Ragland P. L. and Grimes B. (2001): Differential homing and engraftment properties of hematopoietic progenitor cells from murine bone marrow, mobilized peripheral blood, and fetal liver. Blood, 98, 2108-2115.
134. Taichman R. S. and Emerson S. G. (1994): Human osteoblasts support hematopoiesis through the production of granulocyte colony-stimulating factor. J. Exp. Med., 179, 1677-1682.
135. Tajima F., Deguchi T., Laver J. H., Zeng H. and Ogawa M. (2001): Reciprocal expression of CD38 and CD34 by adult murine hematopoietic stem cells. Blood, 97, 2618-2624.
136. Teshima T., Ordemann R., Reddy P., Gagin S., Liu C., Cooke K. R. and Ferrara J. L. (2002): Acute graft-versus-host disease does not require alloantigen expression on host epithelium. Nat. Med., 8, 575-581.
137. Till J. E. and McCulloch E. A. (1961): A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat. Res., 14, 213-222.
138. Truitt R. L. and Atasoylu A. A. (1991): Impact of pre-transplant conditioning and donor T cells on chimerism, graft-versus-host disease, graft-versus-leukemia reactivity, and tolerance after bone marrow transplantation. Blood, 77, 2515-2523.
139. Tsukada N., Kobata T., Aizawa Y., Yagita H. and Okumura K. (1999): Graft-versus-leukemia effect and graft-versus-host disease can be differentiated by cytotoxic mechanisms in a murine model of allogeneic bone marrow transplantation. Blood, 93, 2738-2747.
140. Uchida N., He D., Friera A. M., Reitsma M., Sasaki D., Chen B. and Tsukamoto A. (1997): The unexpected GO/G1 cell cycle status of mobilized hematopoietic stem cells from peripheral blood. Blood, 89, 465-472.
141. Uchida N., Tsukamoto A., He D., Friera A. M., Scollay R. and Weissman I. L. (1998): High doses of purified stem cells cause early hematopoietic recovery in syngeneic and allogeneic hosts. J. Clin. Invest., 101, 961-966.
142. Uharek L., Glass B., Gaska T., Gassmann W., Loeffler H. and Mueller-Ruchholtz W. (1994): Influence of donor lymphocytes on the incidence of primary graft failure after allogeneic bone marrow transplantation in a murine model. Br. J. Haematol., 88, 79-87.
143. van Leeuwen L., Guiffre A., Atkinson K., Rainer S. P. and Sewell W. A. (2002): A two-phase pathogenesis of graft-versus-host disease in mice. Bone Marrow Transplant., 29, 151-158.
144. van Os R., Kamminga L. M. and de Haan G. (2004): Stem cell assays: something old, something new, something borrowed. Stem Cells, 22, 1181-1190.
145. van Os R., Konings A. W. and Down J. D. (1992): Radiation dose as a factor in host preparation for bone marrow transplantation across different genetic barriers. Int. J. Radiat. Biol., 61, 501-510.
146. van Os R., Sheridan T. M., Robinson S., Drukteinis D., Ferrara J. L. and Mauch P. M. (2001): Immunogenicity of Ly5 (CD45)-antigens hampers long-term engraftment following minimal conditioning in a murine bone marrow transplantation model. Stem Cells, 19, 80-87.
147. van Os R., Thames H. D., Konings A. W. and Down J. D. (1993): Radiation dose-fractionation and dose-rate relationships for long-term repopulating hemopoietic stem cells in a murine bone marrow transplant model. Radiat. Res., 136, 118-125.
148. Wagers A. J. and Weissman I. L. (2006): Differential expression of {alpha}2 integrin separates long-term and short-term reconstituting Lin-/loThy1.1loc-kit+Sca-1+ hematopoietic stem cells. Stem Cells, 24, 1087-1094.
149. Wekerle T., Blaha P., Koporc Z., Bigenzahn S., Pusch M. and Muehlbacher F. (2003): Mechanisms of tolerance induction through the transplantation of donor hematopoietic stem cells: central versus peripheral tolerance. Transplantation, 75 (suppl.), 21S-25S.
150. Wekerle T., Blaha P., Langer F., Schmid M. and Muehlbacher F. (2002): Tolerance through bone marrow transplantation with costimulation blockade. Transpl. Immunol., 9, 125-133.
151. Wekerle T., Kurtz J., Ito H., Ronquillo J.V., Dong V., Zhao G., Shaffer J., Sayegh M. H. and Sykes M. (2000): Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment. Nat. Med., 6, 464-469.
152. Westerhof G. R., Ploemacher R. E., Boudewijn A., Blokland I., Dillingh J. H., McGown A. T., Hadfield J. A., Dawson M. J. and Down J. D. (2000): Comparison of different busulfan analogues for depletion of hematopoietic stem cells and promotion of donor-type chimerism in murine bone marrow transplant recipients. Cancer Res., 60, 5470-5478.
153. Wierenga P. K., Setroikromo R., Kamps G., Kampinga H. H. and Vellenga E. (2002): Peripheral blood stem cells differ from bone marrow stem cells in cell cycle status, repopulating potential, and sensitivity toward hyperthermic purging in mice mobilized with cyclophosphamide and granulocyte colony-stimulating factor. J. Hematother. Stem Cell Res., 11, 523-532.
154. Wognum A. W., Eaves A. C. and Thomas T. E. (2003): Identification and isolation of hematopoietic stem cells. Arch. Med. Res., 34, 461-475.
155. Wright D. E., Cheshier S. H., Wagers A. J., Randall T. D., Christensen J. L. and Weissman I. L. (2001): Cyclophosphamide/granulocyte colony-stimulating factor causes selective mobilization of bone marrow hematopoietic stem cells into the blood after M phase of the cell cycle. Blood, 97, 2278-2285.
156. Wright D. E., Wagers A. J., Gulati A. P., Johnson F. L. and Weissman I. L. (2001): Physiological migration of hematopoietic stem and progenitor cells. Science, 294, 1933-1936.
157. Wu D. D. and Keating A. (1993): Hematopoietic stem cells engraft in untreated transplant recipients. Exp. Hematol., 21, 251-256.
158. Wu T., Sozen H., Luo B., Heuss N., Kalscheuer H., Lan P., Sutherland D. E., Hering B. J. and Guo Z. (2002): Rapamycin and T cell costimulatory blockade as posttransplant treatment promote fully MHC-mismatched allogeneic bone marrow engraftment under irradiation-free conditioning therapy. Bone Marrow Transplant., 29, 949-956.
159. Xun C. Q., Thompson J. S., Jennings C. D., Brown S. A. and Widmer M. B. (1994): Effect of total body irradiation, busulfan-cyclophosphamide, or cyclophosphamide conditioning on inflammatory cytokine release and development of acute and chronic graft-versus-host disease in H-2-incompatible transplanted SCID mice. Blood, 83, 2360-2367.
160. Yamamoto Y., Yasumizu R., Amou Y., Watanabe N., Nishio N., Toki J., Fukuhara S. and Ikehara S. (1996): Characterization of peripheral blood stem cells in mice. Blood, 88, 445-454.
161. Yeager A. M., Shinn C. and Pardoll D. M. (1991): Lymphoid reconstitution after transplantation of congenic hematopoietic cells in busulfan-treated mice. Blood, 78, 3312-3316.
162. Yuhas J. M. and Storer J. B. (1969): On mouse strain differences in radiation resistance: hematopoietic death and the endogenous colony-forming unit. Radiat. Res., 39, 608-622.
163. Zeng D., Lewis D., Dejbakhsh-Jones S., Lan F., Garcia-Ojeda M., Sibley R. and Strober S. (1999): Bone marrow NK1.1(-) and NK1.1(+) T cells reciprocally regulate acute graft versus host disease. J. Exp. Med., 189, 1073-1081.
164. Zhang J., Niu C., Ye L., Huang H., He X., Tong W. G., Ross J., Haug J., Johnson T., Feng J. Q., Harris S., Wiedemann L. M., Mishina Y. and Li L. (2003): Identification of the haematopoietic stem cell niche and control of the niche size. Nature, 425, 836-841.
165. Zhong J. F., Zhan Y., Anderson W. F. and Zhao Y. (2002): Murine hematopoietic stem cell distribution and proliferation in ablated and nonablated bone marrow transplantation. Blood, 100, 3521-3526.
166. Zijlmans J. M., Visser J. W., Laterveer L., Kleiverda K., Heemskerk D. P., Kluin P. M., Willemze R. and Fibbe W. E. (1998): The early phase of engraftment after murine blood cell transplantation is mediated by hematopoietic stem cells. Proc. Natl. Acad. Sci. USA, 95, 725-729.